SWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ Transplant

NCT00002657 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

NETWORK

Sponsor class

Conditions

Lymphoma
Multiple Myeloma and Plasma Cell Neoplasm

Interventions

BIOLOGICAL: bleomycin sulfate
BIOLOGICAL: recombinant interferon alfa
DRUG: cyclophosphamide
DRUG: cytarabine
DRUG: doxorubicin hydrochloride
DRUG: etoposide
DRUG: methotrexate
DRUG: prednisone
DRUG: vincristine sulfate
PROCEDURE: conventional surgery
RADIATION: radiation therapy

Sponsor

SWOG Cancer Research Network

Collaborators

[object Object]
[object Object]